Canada markets open in 4 hours 33 minutes

Lucid Diagnostics Inc. (LUCD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.8600-0.0900 (-4.62%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.9500
Open1.9600
Bid0.0000 x 900
Ask0.0000 x 1000
Day's Range1.8100 - 1.9600
52 Week Range1.5100 - 7.7250
Volume65,554
Avg. Volume63,952
Market Cap72.74M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    PAVmed Provides Business Update and Third Quarter 2022 Financial Results

    NEW YORK, November 15, 2022--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the three and nine months ended September 30, 2022.

  • Business Wire

    Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results

    NEW YORK, November 14, 2022--Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today provided a business update for the Company and presented financial results for the three and nine months ended September 30, 2022.

  • Business Wire

    Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum

    NEW YORK, November 10, 2022--Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid", the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today announced that Lishan Aklog, M.D., the Lucid’s Chairman and Chief Executive Officer, will present an overview of the Company at the CG MedTech, Diagnostics and Digital Health & Services Forum taking place on November 17, 2022 from 11:00 am to 11:25 am EST